Rank | Gene Set | Z-score |
---|---|---|
1 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.81564471 |
2 | DNA strand elongation (GO:0022616) | 4.62164685 |
3 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.61016053 |
4 | ribosomal small subunit assembly (GO:0000028) | 4.53759820 |
5 | DNA unwinding involved in DNA replication (GO:0006268) | 4.47987589 |
6 | DNA replication initiation (GO:0006270) | 4.35436844 |
7 | telomere maintenance via recombination (GO:0000722) | 4.14061090 |
8 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.01023046 |
9 | mitotic recombination (GO:0006312) | 3.98969654 |
10 | maturation of SSU-rRNA (GO:0030490) | 3.91506938 |
11 | DNA replication checkpoint (GO:0000076) | 3.89370569 |
12 | DNA deamination (GO:0045006) | 3.76504649 |
13 | formation of translation preinitiation complex (GO:0001731) | 3.70006577 |
14 | nucleobase biosynthetic process (GO:0046112) | 3.67191170 |
15 | telomere maintenance via telomere lengthening (GO:0010833) | 3.66534800 |
16 | mitotic metaphase plate congression (GO:0007080) | 3.57490475 |
17 | protein localization to kinetochore (GO:0034501) | 3.57452729 |
18 | nuclear pore complex assembly (GO:0051292) | 3.52685933 |
19 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.52056477 |
20 | IMP biosynthetic process (GO:0006188) | 3.50403849 |
21 | DNA ligation (GO:0006266) | 3.49168778 |
22 | establishment of integrated proviral latency (GO:0075713) | 3.47776792 |
23 | purine nucleobase biosynthetic process (GO:0009113) | 3.43357134 |
24 | viral transcription (GO:0019083) | 3.42568680 |
25 | DNA damage response, detection of DNA damage (GO:0042769) | 3.42124289 |
26 | mitotic chromosome condensation (GO:0007076) | 3.41955105 |
27 | mitotic nuclear envelope disassembly (GO:0007077) | 3.41472552 |
28 | metaphase plate congression (GO:0051310) | 3.40252783 |
29 | meiotic chromosome segregation (GO:0045132) | 3.37093615 |
30 | translational termination (GO:0006415) | 3.35270922 |
31 | CENP-A containing nucleosome assembly (GO:0034080) | 3.35225877 |
32 | establishment of chromosome localization (GO:0051303) | 3.27587461 |
33 | regulation of spindle organization (GO:0090224) | 3.25339269 |
34 | chromatin remodeling at centromere (GO:0031055) | 3.25144116 |
35 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.24785550 |
36 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.24785550 |
37 | ribosomal small subunit biogenesis (GO:0042274) | 3.22625859 |
38 | kinetochore organization (GO:0051383) | 3.18869768 |
39 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.18537024 |
40 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.18537024 |
41 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.16503115 |
42 | IMP metabolic process (GO:0046040) | 3.14661083 |
43 | translational elongation (GO:0006414) | 3.14252143 |
44 | protein localization to chromosome, centromeric region (GO:0071459) | 3.12819810 |
45 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.10870314 |
46 | non-recombinational repair (GO:0000726) | 3.10870314 |
47 | ribosome biogenesis (GO:0042254) | 3.10496483 |
48 | mismatch repair (GO:0006298) | 3.09568125 |
49 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.07993098 |
50 | nuclear envelope disassembly (GO:0051081) | 3.06730672 |
51 | membrane disassembly (GO:0030397) | 3.06730672 |
52 | DNA replication-independent nucleosome organization (GO:0034724) | 3.04276323 |
53 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.04276323 |
54 | DNA duplex unwinding (GO:0032508) | 3.01763370 |
55 | DNA geometric change (GO:0032392) | 3.01075926 |
56 | pore complex assembly (GO:0046931) | 3.01004178 |
57 | ribosomal large subunit biogenesis (GO:0042273) | 3.00885574 |
58 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.00566689 |
59 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.99586951 |
60 | proteasome assembly (GO:0043248) | 2.99549264 |
61 | histone H2A acetylation (GO:0043968) | 2.99451744 |
62 | telomere organization (GO:0032200) | 2.98264518 |
63 | translational initiation (GO:0006413) | 2.98220607 |
64 | telomere maintenance (GO:0000723) | 2.97676176 |
65 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.97265900 |
66 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.97265900 |
67 | mitochondrial RNA metabolic process (GO:0000959) | 2.97133762 |
68 | DNA double-strand break processing (GO:0000729) | 2.95779321 |
69 | DNA topological change (GO:0006265) | 2.95166882 |
70 | regulation of mitotic spindle organization (GO:0060236) | 2.94350697 |
71 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.92593272 |
72 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.91950533 |
73 | kinetochore assembly (GO:0051382) | 2.91687717 |
74 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.91010798 |
75 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.91010798 |
76 | base-excision repair (GO:0006284) | 2.90917217 |
77 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.89290562 |
78 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.88851088 |
79 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.88851088 |
80 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.88851088 |
81 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.88621226 |
82 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.88282417 |
83 | mitotic sister chromatid segregation (GO:0000070) | 2.88191362 |
84 | viral mRNA export from host cell nucleus (GO:0046784) | 2.85221651 |
85 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.84307079 |
86 | rRNA processing (GO:0006364) | 2.84205718 |
87 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.84044817 |
88 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.83052919 |
89 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.83052919 |
90 | mitotic spindle checkpoint (GO:0071174) | 2.81983206 |
91 | ribosome assembly (GO:0042255) | 2.81907501 |
92 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.81131615 |
93 | pseudouridine synthesis (GO:0001522) | 2.79986876 |
94 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.79710294 |
95 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.79255598 |
96 | negative regulation of ligase activity (GO:0051352) | 2.79255598 |
97 | chromosome segregation (GO:0007059) | 2.79094324 |
98 | establishment of viral latency (GO:0019043) | 2.78917477 |
99 | regulation of spindle checkpoint (GO:0090231) | 2.78809450 |
100 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.78391165 |
101 | cotranslational protein targeting to membrane (GO:0006613) | 2.78045570 |
102 | synapsis (GO:0007129) | 2.77463624 |
103 | rRNA metabolic process (GO:0016072) | 2.77054573 |
104 | positive regulation of chromosome segregation (GO:0051984) | 2.76449708 |
105 | protein targeting to ER (GO:0045047) | 2.75790831 |
106 | regulation of translation in response to stress (GO:0043555) | 2.74021780 |
107 | spindle checkpoint (GO:0031577) | 2.73436375 |
108 | maturation of 5.8S rRNA (GO:0000460) | 2.71885439 |
109 | spliceosomal snRNP assembly (GO:0000387) | 2.71766983 |
110 | negative regulation of chromosome segregation (GO:0051985) | 2.71739484 |
111 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.71018265 |
112 | negative regulation of sister chromatid segregation (GO:0033046) | 2.71018265 |
113 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.71018265 |
114 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.71018265 |
115 | cell cycle G1/S phase transition (GO:0044843) | 2.70980826 |
116 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.70980826 |
117 | mitotic spindle assembly checkpoint (GO:0007094) | 2.70858088 |
118 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.69709746 |
119 | tRNA aminoacylation for protein translation (GO:0006418) | 2.69681281 |
120 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.68227344 |
121 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.67045118 |
122 | histone exchange (GO:0043486) | 2.67036447 |
123 | sister chromatid segregation (GO:0000819) | 2.66470316 |
124 | nuclear pore organization (GO:0006999) | 2.66104324 |
125 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.65927225 |
126 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.65266784 |
127 | postreplication repair (GO:0006301) | 2.65189258 |
128 | viral life cycle (GO:0019058) | 2.65186988 |
129 | positive regulation of B cell differentiation (GO:0045579) | 2.64181533 |
130 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.63972623 |
131 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.63801552 |
132 | cellular protein complex disassembly (GO:0043624) | 2.63677802 |
133 | spindle assembly checkpoint (GO:0071173) | 2.62033842 |
134 | RNA splicing, via transesterification reactions (GO:0000375) | 2.61947675 |
135 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.61938448 |
136 | mRNA splicing, via spliceosome (GO:0000398) | 2.61938448 |
137 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.61858424 |
138 | positive regulation of ligase activity (GO:0051351) | 2.61456336 |
139 | tRNA aminoacylation (GO:0043039) | 2.61453623 |
140 | amino acid activation (GO:0043038) | 2.61453623 |
141 | piRNA metabolic process (GO:0034587) | 2.59171198 |
142 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.58126635 |
143 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.58126635 |
144 | transcription from mitochondrial promoter (GO:0006390) | 2.57109041 |
145 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.52671919 |
146 | regulation of chromosome segregation (GO:0051983) | 2.51386593 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.77860845 |
2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.83190411 |
3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.73288572 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.57658073 |
5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.44149554 |
6 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.11857125 |
7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.80578629 |
8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.74718032 |
9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.59057172 |
10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.54938829 |
11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.53165168 |
12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.51085493 |
13 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.51041368 |
14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.45962731 |
15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.43523325 |
16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.34041137 |
17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.26600223 |
18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.17625951 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.15457575 |
20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.15277547 |
21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.14025273 |
22 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.13937998 |
23 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.13449012 |
24 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.10782821 |
25 | MYC_22102868_ChIP-Seq_BL_Human | 2.05114249 |
26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.98484883 |
27 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.91951595 |
28 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.90108080 |
29 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.86345661 |
30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.85479820 |
31 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85023017 |
32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.81911151 |
33 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.79521547 |
34 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.73989482 |
35 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.73489111 |
36 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.71597555 |
37 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.66674437 |
38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65422311 |
39 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64818007 |
40 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62556885 |
41 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.62008373 |
42 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.61937908 |
43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.61153758 |
44 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.60699682 |
45 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.57533545 |
46 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.57056202 |
47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.55101652 |
48 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.54878619 |
49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.54492948 |
50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53422154 |
51 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.53222191 |
52 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.49724164 |
53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46520571 |
54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43496919 |
55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.41053164 |
56 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.40685405 |
57 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40165156 |
58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37223482 |
59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35493881 |
60 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.35020921 |
61 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.34963677 |
62 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.32315318 |
63 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.32303205 |
64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.31660772 |
65 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.31394390 |
66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.27265332 |
67 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.26137864 |
68 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24534097 |
69 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.23937580 |
70 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.21094851 |
71 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20579151 |
72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16690291 |
73 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15588696 |
74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13791097 |
75 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.12204415 |
76 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.09994904 |
77 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07758867 |
78 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06946871 |
79 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.06886712 |
80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05968121 |
81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05585946 |
82 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04696788 |
83 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.04454521 |
84 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.00275169 |
85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99466905 |
86 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.98942730 |
87 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.98297290 |
88 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96840234 |
89 | MYB_26560356_Chip-Seq_TH2_Human | 0.96506736 |
90 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.96085975 |
91 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95624863 |
92 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.94361933 |
93 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.93562740 |
94 | MYB_26560356_Chip-Seq_TH1_Human | 0.90688147 |
95 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90305030 |
96 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89927381 |
97 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.89717929 |
98 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.89603072 |
99 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.89456464 |
100 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.89144573 |
101 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.88961373 |
102 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.88174149 |
103 | MAF_26560356_Chip-Seq_TH1_Human | 0.87622740 |
104 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.86707253 |
105 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.86485124 |
106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84846740 |
107 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.84322624 |
108 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.82994909 |
109 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.81220110 |
110 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.81196335 |
111 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.80958673 |
112 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78226930 |
113 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.74523632 |
114 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.73268871 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 4.66450790 |
2 | MP0010094_abnormal_chromosome_stability | 4.23764680 |
3 | MP0003111_abnormal_nucleus_morphology | 3.89565948 |
4 | MP0003077_abnormal_cell_cycle | 3.63092905 |
5 | MP0004957_abnormal_blastocyst_morpholog | 3.59254006 |
6 | MP0008057_abnormal_DNA_replication | 3.58739071 |
7 | MP0002396_abnormal_hematopoietic_system | 3.36064143 |
8 | MP0008058_abnormal_DNA_repair | 2.99966839 |
9 | MP0000372_irregular_coat_pigmentation | 2.76427386 |
10 | MP0008007_abnormal_cellular_replicative | 2.57420080 |
11 | MP0000015_abnormal_ear_pigmentation | 2.27721087 |
12 | MP0008932_abnormal_embryonic_tissue | 2.15917908 |
13 | MP0004808_abnormal_hematopoietic_stem | 2.15041518 |
14 | MP0003172_abnormal_lysosome_physiology | 2.09804931 |
15 | MP0003763_abnormal_thymus_physiology | 2.05115850 |
16 | MP0000490_abnormal_crypts_of | 2.04253030 |
17 | MP0002102_abnormal_ear_morphology | 2.02584482 |
18 | MP0005671_abnormal_response_to | 1.91624464 |
19 | MP0006035_abnormal_mitochondrial_morpho | 1.86212723 |
20 | MP0009333_abnormal_splenocyte_physiolog | 1.85440596 |
21 | MP0000350_abnormal_cell_proliferation | 1.84929088 |
22 | MP0001730_embryonic_growth_arrest | 1.83111432 |
23 | MP0001545_abnormal_hematopoietic_system | 1.78367204 |
24 | MP0005397_hematopoietic_system_phenotyp | 1.78367204 |
25 | MP0002398_abnormal_bone_marrow | 1.78275316 |
26 | MP0002138_abnormal_hepatobiliary_system | 1.76423270 |
27 | MP0010352_gastrointestinal_tract_polyps | 1.75489959 |
28 | MP0001835_abnormal_antigen_presentation | 1.74215832 |
29 | MP0006054_spinal_hemorrhage | 1.67354577 |
30 | MP0006036_abnormal_mitochondrial_physio | 1.66063042 |
31 | MP0008877_abnormal_DNA_methylation | 1.65933626 |
32 | MP0008995_early_reproductive_senescence | 1.63369704 |
33 | MP0000685_abnormal_immune_system | 1.61626076 |
34 | MP0002722_abnormal_immune_system | 1.60463028 |
35 | MP0003786_premature_aging | 1.58552187 |
36 | MP0000465_gastrointestinal_hemorrhage | 1.55095415 |
37 | MP0000689_abnormal_spleen_morphology | 1.54955784 |
38 | MP0000703_abnormal_thymus_morphology | 1.53926931 |
39 | MP0002019_abnormal_tumor_incidence | 1.49412723 |
40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.47624759 |
41 | MP0000313_abnormal_cell_death | 1.47066517 |
42 | MP0010307_abnormal_tumor_latency | 1.45067626 |
43 | MP0001800_abnormal_humoral_immune | 1.44970556 |
44 | MP0003656_abnormal_erythrocyte_physiolo | 1.42875632 |
45 | MP0003806_abnormal_nucleotide_metabolis | 1.41454551 |
46 | MP0002429_abnormal_blood_cell | 1.40629248 |
47 | MP0001672_abnormal_embryogenesis/_devel | 1.38053811 |
48 | MP0005380_embryogenesis_phenotype | 1.38053811 |
49 | MP0000716_abnormal_immune_system | 1.37852117 |
50 | MP0001697_abnormal_embryo_size | 1.36565595 |
51 | MP0002420_abnormal_adaptive_immunity | 1.34585772 |
52 | MP0002452_abnormal_antigen_presenting | 1.34505691 |
53 | MP0001819_abnormal_immune_cell | 1.33244626 |
54 | MP0005084_abnormal_gallbladder_morpholo | 1.31526505 |
55 | MP0001853_heart_inflammation | 1.28154409 |
56 | MP0003436_decreased_susceptibility_to | 1.27240194 |
57 | MP0003984_embryonic_growth_retardation | 1.26771097 |
58 | MP0002080_prenatal_lethality | 1.25929847 |
59 | MP0002088_abnormal_embryonic_growth/wei | 1.23183899 |
60 | MP0005464_abnormal_platelet_physiology | 1.22288580 |
61 | MP0003303_peritoneal_inflammation | 1.20563810 |
62 | MP0002405_respiratory_system_inflammati | 1.18986278 |
63 | MP0002723_abnormal_immune_serum | 1.18787319 |
64 | MP0002132_abnormal_respiratory_system | 1.15884860 |
65 | MP0005075_abnormal_melanosome_morpholog | 1.14355219 |
66 | MP0010155_abnormal_intestine_physiology | 1.14108661 |
67 | MP0008789_abnormal_olfactory_epithelium | 1.13668086 |
68 | MP0003567_abnormal_fetal_cardiomyocyte | 1.13144474 |
69 | MP0003718_maternal_effect | 1.10829440 |
70 | MP0005025_abnormal_response_to | 1.10706559 |
71 | MP0005451_abnormal_body_composition | 1.09777750 |
72 | MP0002085_abnormal_embryonic_tissue | 1.09013465 |
73 | MP0009785_altered_susceptibility_to | 1.08964432 |
74 | MP0003123_paternal_imprinting | 1.08402330 |
75 | MP0002086_abnormal_extraembryonic_tissu | 1.08084416 |
76 | MP0005000_abnormal_immune_tolerance | 1.07776366 |
77 | MP0003315_abnormal_perineum_morphology | 1.06609348 |
78 | MP0009278_abnormal_bone_marrow | 1.01865435 |
79 | MP0008260_abnormal_autophagy | 0.97632220 |
80 | MP0004147_increased_porphyrin_level | 0.96690227 |
81 | MP0010030_abnormal_orbit_morphology | 0.96239594 |
82 | MP0002419_abnormal_innate_immunity | 0.96065420 |
83 | MP0005076_abnormal_cell_differentiation | 0.94391281 |
84 | MP0001529_abnormal_vocalization | 0.93711155 |
85 | MP0002084_abnormal_developmental_patter | 0.92876199 |
86 | MP0001915_intracranial_hemorrhage | 0.92270471 |
87 | MP0000858_altered_metastatic_potential | 0.92228902 |
88 | MP0002751_abnormal_autonomic_nervous | 0.91394235 |
89 | MP0002210_abnormal_sex_determination | 0.91320814 |
90 | MP0001293_anophthalmia | 0.90773141 |
91 | MP0005387_immune_system_phenotype | 0.89521209 |
92 | MP0001790_abnormal_immune_system | 0.89521209 |
93 | MP0002148_abnormal_hypersensitivity_rea | 0.89378384 |
94 | MP0005023_abnormal_wound_healing | 0.89373911 |
95 | MP0001119_abnormal_female_reproductive | 0.88573510 |
96 | MP0005394_taste/olfaction_phenotype | 0.88531532 |
97 | MP0005499_abnormal_olfactory_system | 0.88531532 |
98 | MP0004264_abnormal_extraembryonic_tissu | 0.86519859 |
99 | MP0000371_diluted_coat_color | 0.86451276 |
100 | MP0002269_muscular_atrophy | 0.86197301 |
101 | MP0005395_other_phenotype | 0.85055840 |
102 | MP0004197_abnormal_fetal_growth/weight/ | 0.83895066 |
103 | MP0005621_abnormal_cell_physiology | 0.83881237 |
104 | MP0003186_abnormal_redox_activity | 0.82904995 |
105 | MP0002166_altered_tumor_susceptibility | 0.81336986 |
106 | MP0005266_abnormal_metabolism | 0.80583801 |
107 | MP0006292_abnormal_olfactory_placode | 0.80444975 |
108 | MP0005384_cellular_phenotype | 0.78882111 |
109 | MP0004381_abnormal_hair_follicle | 0.78880698 |
110 | MP0001845_abnormal_inflammatory_respons | 0.78799054 |
111 | MP0003566_abnormal_cell_adhesion | 0.77035287 |
112 | MP0001145_abnormal_male_reproductive | 0.76175918 |
113 | MP0002006_tumorigenesis | 0.74571638 |
114 | MP0001873_stomach_inflammation | 0.74073996 |
115 | MP0000477_abnormal_intestine_morphology | 0.73727119 |
116 | MP0003866_abnormal_defecation | 0.73508547 |
117 | MP0002234_abnormal_pharynx_morphology | 0.72297515 |
118 | MP0005058_abnormal_lysosome_morphology | 0.72192031 |
119 | MP0003121_genomic_imprinting | 0.72021776 |
120 | MP0003699_abnormal_female_reproductive | 0.71698003 |
121 | MP0005174_abnormal_tail_pigmentation | 0.71372235 |
122 | MP0001929_abnormal_gametogenesis | 0.71092513 |
123 | MP0002095_abnormal_skin_pigmentation | 0.70265944 |
124 | MP0000358_abnormal_cell_content/ | 0.69354896 |
125 | MP0000653_abnormal_sex_gland | 0.65553943 |
126 | MP0000343_altered_response_to | 0.64009813 |
127 | MP0009697_abnormal_copulation | 0.63454363 |
128 | MP0003943_abnormal_hepatobiliary_system | 0.62968103 |
129 | MP0008469_abnormal_protein_level | 0.62383600 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Birth length less than 3rd percentile (HP:0003561) | 4.40746219 |
2 | Reticulocytopenia (HP:0001896) | 4.26670074 |
3 | Colon cancer (HP:0003003) | 3.78588529 |
4 | Aplastic anemia (HP:0001915) | 3.78289910 |
5 | Chromsome breakage (HP:0040012) | 3.76033230 |
6 | Agnosia (HP:0010524) | 3.58557691 |
7 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.46169485 |
8 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.35664113 |
9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.32699723 |
10 | Acute necrotizing encephalopathy (HP:0006965) | 3.29227858 |
11 | Oral leukoplakia (HP:0002745) | 3.28315337 |
12 | Abnormal number of erythroid precursors (HP:0012131) | 3.22050909 |
13 | Cholecystitis (HP:0001082) | 3.18707961 |
14 | Abnormal gallbladder physiology (HP:0012438) | 3.18707961 |
15 | Breast hypoplasia (HP:0003187) | 3.04798980 |
16 | Hepatocellular necrosis (HP:0001404) | 3.01976852 |
17 | Petechiae (HP:0000967) | 3.01961244 |
18 | Medulloblastoma (HP:0002885) | 2.99182151 |
19 | IgM deficiency (HP:0002850) | 2.96716349 |
20 | Acute encephalopathy (HP:0006846) | 2.93882603 |
21 | Patellar aplasia (HP:0006443) | 2.92934318 |
22 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.92535142 |
23 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.92535142 |
24 | Abnormal protein glycosylation (HP:0012346) | 2.92535142 |
25 | Abnormal glycosylation (HP:0012345) | 2.92535142 |
26 | Abnormality of the anterior horn cell (HP:0006802) | 2.88296307 |
27 | Degeneration of anterior horn cells (HP:0002398) | 2.88296307 |
28 | Chronic otitis media (HP:0000389) | 2.82378084 |
29 | Abnormality of the preputium (HP:0100587) | 2.82013910 |
30 | Abnormality of chromosome stability (HP:0003220) | 2.80771272 |
31 | Hepatic necrosis (HP:0002605) | 2.79169733 |
32 | Mitochondrial inheritance (HP:0001427) | 2.76598964 |
33 | Increased CSF lactate (HP:0002490) | 2.75969170 |
34 | Meckel diverticulum (HP:0002245) | 2.72737561 |
35 | Selective tooth agenesis (HP:0001592) | 2.72175353 |
36 | Abnormality of the ileum (HP:0001549) | 2.70671769 |
37 | Ependymoma (HP:0002888) | 2.69253260 |
38 | Thrombocytosis (HP:0001894) | 2.68330084 |
39 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.67925511 |
40 | Albinism (HP:0001022) | 2.65912404 |
41 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.64445041 |
42 | Myelodysplasia (HP:0002863) | 2.63558051 |
43 | 11 pairs of ribs (HP:0000878) | 2.62419312 |
44 | Ectopic kidney (HP:0000086) | 2.61157612 |
45 | Rough bone trabeculation (HP:0100670) | 2.59393977 |
46 | Progressive macrocephaly (HP:0004481) | 2.57761396 |
47 | Absent thumb (HP:0009777) | 2.56852205 |
48 | Bone marrow hypocellularity (HP:0005528) | 2.51615539 |
49 | Abnormality of the labia minora (HP:0012880) | 2.50185614 |
50 | Carpal bone hypoplasia (HP:0001498) | 2.47804717 |
51 | Small intestinal stenosis (HP:0012848) | 2.42376888 |
52 | Duodenal stenosis (HP:0100867) | 2.42376888 |
53 | Lymphoma (HP:0002665) | 2.41675348 |
54 | Panhypogammaglobulinemia (HP:0003139) | 2.40440538 |
55 | Pallor (HP:0000980) | 2.37558353 |
56 | Increased intramyocellular lipid droplets (HP:0012240) | 2.33565473 |
57 | Amaurosis fugax (HP:0100576) | 2.32822703 |
58 | Increased serum lactate (HP:0002151) | 2.29752885 |
59 | Macrocytic anemia (HP:0001972) | 2.29517131 |
60 | Basal cell carcinoma (HP:0002671) | 2.27985190 |
61 | Premature graying of hair (HP:0002216) | 2.25091043 |
62 | Increased muscle lipid content (HP:0009058) | 2.23380233 |
63 | Neoplasm of the adrenal cortex (HP:0100641) | 2.23281027 |
64 | Neoplasm of the adrenal gland (HP:0100631) | 2.23125573 |
65 | Recurrent abscess formation (HP:0002722) | 2.22672285 |
66 | Rhabdomyosarcoma (HP:0002859) | 2.21223978 |
67 | Optic nerve coloboma (HP:0000588) | 2.20700176 |
68 | Methylmalonic acidemia (HP:0002912) | 2.20686988 |
69 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.19668370 |
70 | Clubbing of toes (HP:0100760) | 2.19644273 |
71 | Volvulus (HP:0002580) | 2.19102371 |
72 | Cerebral hypomyelination (HP:0006808) | 2.15468277 |
73 | Lipid accumulation in hepatocytes (HP:0006561) | 2.13832377 |
74 | Abnormal number of incisors (HP:0011064) | 2.13595386 |
75 | Exercise intolerance (HP:0003546) | 2.11269338 |
76 | Cerebral edema (HP:0002181) | 2.11157070 |
77 | Recurrent viral infections (HP:0004429) | 2.10860736 |
78 | Respiratory failure (HP:0002878) | 2.10476391 |
79 | Neoplasm of the pancreas (HP:0002894) | 2.05888806 |
80 | Abnormality of the prostate (HP:0008775) | 2.05590700 |
81 | Lactic acidosis (HP:0003128) | 2.05562253 |
82 | Sloping forehead (HP:0000340) | 2.04905931 |
83 | Microvesicular hepatic steatosis (HP:0001414) | 2.03304893 |
84 | Severe combined immunodeficiency (HP:0004430) | 2.01360402 |
85 | Tracheoesophageal fistula (HP:0002575) | 1.99015745 |
86 | Multiple enchondromatosis (HP:0005701) | 1.98930746 |
87 | Trismus (HP:0000211) | 1.97172248 |
88 | Progressive muscle weakness (HP:0003323) | 1.96712249 |
89 | Horseshoe kidney (HP:0000085) | 1.96272292 |
90 | Pancytopenia (HP:0001876) | 1.95267112 |
91 | Pulmonary fibrosis (HP:0002206) | 1.95263214 |
92 | Abnormality of the duodenum (HP:0002246) | 1.94867150 |
93 | Increased hepatocellular lipid droplets (HP:0006565) | 1.94831980 |
94 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.94380136 |
95 | Nausea (HP:0002018) | 1.94226460 |
96 | Abnormal trabecular bone morphology (HP:0100671) | 1.93353231 |
97 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.91694816 |
98 | Cellular immunodeficiency (HP:0005374) | 1.90120051 |
99 | Cellulitis (HP:0100658) | 1.89716910 |
100 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89673259 |
101 | Obstructive lung disease (HP:0006536) | 1.89673259 |
102 | Pustule (HP:0200039) | 1.87914776 |
103 | Abnormality of DNA repair (HP:0003254) | 1.87489254 |
104 | Triphalangeal thumb (HP:0001199) | 1.87470173 |
105 | Short middle phalanx of the 5th finger (HP:0004220) | 1.86451302 |
106 | Abnormal lung lobation (HP:0002101) | 1.86368662 |
107 | Agammaglobulinemia (HP:0004432) | 1.86275073 |
108 | Abnormality of T cells (HP:0002843) | 1.86253743 |
109 | Acute myeloid leukemia (HP:0004808) | 1.84739143 |
110 | Slender long bone (HP:0003100) | 1.84084434 |
111 | CNS hypomyelination (HP:0003429) | 1.83995383 |
112 | Type I transferrin isoform profile (HP:0003642) | 1.83479337 |
113 | Absent radius (HP:0003974) | 1.82683978 |
114 | Abnormality of T cell physiology (HP:0011840) | 1.82477541 |
115 | Poor head control (HP:0002421) | 1.81519001 |
116 | Neoplasm of the oral cavity (HP:0100649) | 1.80222642 |
117 | Recurrent bacterial skin infections (HP:0005406) | 1.80023283 |
118 | Impulsivity (HP:0100710) | 1.78143954 |
119 | Abnormality of glycolysis (HP:0004366) | 1.77517513 |
120 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77509236 |
121 | Methylmalonic aciduria (HP:0012120) | 1.77378532 |
122 | Spastic paraparesis (HP:0002313) | 1.77312965 |
123 | Increased serum pyruvate (HP:0003542) | 1.77308524 |
124 | Acute lymphatic leukemia (HP:0006721) | 1.76949190 |
125 | Leukopenia (HP:0001882) | 1.76892062 |
126 | Muscle fiber atrophy (HP:0100295) | 1.76747165 |
127 | Combined immunodeficiency (HP:0005387) | 1.76579716 |
128 | Poikiloderma (HP:0001029) | 1.75522591 |
129 | Dicarboxylic aciduria (HP:0003215) | 1.75122596 |
130 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.75122596 |
131 | Lymphopenia (HP:0001888) | 1.75116677 |
132 | Recurrent bronchitis (HP:0002837) | 1.75008612 |
133 | Neoplasm of the colon (HP:0100273) | 1.74263897 |
134 | Duplicated collecting system (HP:0000081) | 1.74261563 |
135 | Cleft eyelid (HP:0000625) | 1.74099733 |
136 | Type 2 muscle fiber atrophy (HP:0003554) | 1.74075447 |
137 | Reduced antithrombin III activity (HP:0001976) | 1.73596959 |
138 | Shoulder girdle muscle weakness (HP:0003547) | 1.73110111 |
139 | IgG deficiency (HP:0004315) | 1.73087412 |
140 | Hypokinesia (HP:0002375) | 1.72349737 |
141 | Long eyelashes (HP:0000527) | 1.72349582 |
142 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.72297096 |
143 | Abnormality of reticulocytes (HP:0004312) | 1.71500137 |
144 | Sparse eyelashes (HP:0000653) | 1.71276332 |
145 | Generalized aminoaciduria (HP:0002909) | 1.70929933 |
146 | Cortical dysplasia (HP:0002539) | 1.70658112 |
147 | Granulocytopenia (HP:0001913) | 1.70296662 |
148 | Premature ovarian failure (HP:0008209) | 1.69153253 |
149 | B lymphocytopenia (HP:0010976) | 1.68826653 |
150 | Hypertensive crisis (HP:0100735) | 1.67860100 |
151 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.66539032 |
152 | Cholelithiasis (HP:0001081) | 1.66505910 |
153 | Respiratory difficulties (HP:0002880) | 1.65697564 |
154 | Cutis marmorata (HP:0000965) | 1.65519907 |
155 | Broad alveolar ridges (HP:0000187) | 1.63824479 |
156 | CNS demyelination (HP:0007305) | 1.63773851 |
157 | Iris hypopigmentation (HP:0007730) | 1.62969619 |
158 | Emotional lability (HP:0000712) | 1.62391199 |
159 | Hypergonadotropic hypogonadism (HP:0000815) | 1.62343264 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BUB1 | 3.70904210 |
2 | VRK2 | 3.66088779 |
3 | MAP4K2 | 3.60307401 |
4 | CDC7 | 3.58440649 |
5 | WEE1 | 3.50750021 |
6 | EIF2AK1 | 3.02425009 |
7 | MAP4K1 | 2.57461709 |
8 | NEK2 | 2.16424401 |
9 | STK10 | 2.08547318 |
10 | STK16 | 2.01946532 |
11 | NME2 | 2.01923729 |
12 | ACVR1B | 1.98416565 |
13 | TSSK6 | 1.98109115 |
14 | BRSK2 | 1.91242693 |
15 | RIPK4 | 1.91096830 |
16 | RPS6KB2 | 1.89322878 |
17 | PASK | 1.78114465 |
18 | PIM2 | 1.76257551 |
19 | PLK4 | 1.75991973 |
20 | PLK1 | 1.71227075 |
21 | TAOK3 | 1.69188646 |
22 | BTK | 1.68292913 |
23 | CCNB1 | 1.67269486 |
24 | ATR | 1.66814801 |
25 | TTK | 1.63782935 |
26 | CDK7 | 1.63302485 |
27 | NEK1 | 1.63096165 |
28 | TESK2 | 1.62612424 |
29 | RPS6KA4 | 1.61912036 |
30 | EEF2K | 1.57818451 |
31 | MAP2K3 | 1.55827900 |
32 | TEC | 1.52737677 |
33 | MKNK1 | 1.50657895 |
34 | EIF2AK3 | 1.49586387 |
35 | KIT | 1.47228078 |
36 | CDK12 | 1.46602824 |
37 | TGFBR1 | 1.45061632 |
38 | MST4 | 1.44958220 |
39 | VRK1 | 1.44137504 |
40 | TRIM28 | 1.41156674 |
41 | AURKB | 1.40894813 |
42 | SRPK1 | 1.40642573 |
43 | PDK2 | 1.36504990 |
44 | DYRK3 | 1.33119689 |
45 | PBK | 1.32180354 |
46 | RAF1 | 1.30068316 |
47 | MAP3K8 | 1.29487362 |
48 | BRSK1 | 1.28058044 |
49 | PIM1 | 1.23760833 |
50 | MAP3K10 | 1.20529082 |
51 | KDR | 1.17466282 |
52 | TXK | 1.12237506 |
53 | CDK4 | 1.11410911 |
54 | ZAP70 | 1.10178226 |
55 | IRAK4 | 1.08813965 |
56 | PLK3 | 1.05608994 |
57 | LRRK2 | 1.03989930 |
58 | SMG1 | 1.03658725 |
59 | CDK19 | 1.02899188 |
60 | CHEK2 | 0.97236619 |
61 | CLK1 | 0.96983084 |
62 | CHEK1 | 0.92439952 |
63 | TAF1 | 0.91562297 |
64 | AURKA | 0.91224532 |
65 | JAK3 | 0.90298840 |
66 | CSNK1G3 | 0.87288986 |
67 | RPS6KA5 | 0.87093593 |
68 | TNK2 | 0.86606633 |
69 | BLK | 0.85836356 |
70 | TYK2 | 0.84388116 |
71 | CSF1R | 0.84318892 |
72 | SYK | 0.83978209 |
73 | STK4 | 0.81308133 |
74 | CDK8 | 0.81074951 |
75 | PAK4 | 0.80833786 |
76 | CSNK1G2 | 0.77809441 |
77 | NME1 | 0.77745116 |
78 | BRD4 | 0.77679246 |
79 | MAP3K11 | 0.76153177 |
80 | ERN1 | 0.75102583 |
81 | CDK3 | 0.74937029 |
82 | CDK9 | 0.74636587 |
83 | ITK | 0.74211499 |
84 | MAPKAPK5 | 0.73349920 |
85 | MKNK2 | 0.70501221 |
86 | CSNK1G1 | 0.68481709 |
87 | TESK1 | 0.68035847 |
88 | ATM | 0.67761203 |
89 | FLT3 | 0.66865965 |
90 | TLK1 | 0.66588450 |
91 | CDK2 | 0.66067572 |
92 | BMPR2 | 0.65955829 |
93 | CSNK1A1L | 0.64112256 |
94 | LYN | 0.62809368 |
95 | MAPK11 | 0.61454224 |
96 | MAP3K14 | 0.60474748 |
97 | TAOK2 | 0.59990575 |
98 | SIK3 | 0.58549255 |
99 | SCYL2 | 0.58240580 |
100 | NUAK1 | 0.57274358 |
101 | EIF2AK2 | 0.56921411 |
102 | RPS6KA6 | 0.56838163 |
103 | DAPK1 | 0.56691117 |
104 | PAK1 | 0.56583636 |
105 | BRAF | 0.56445711 |
106 | RPS6KL1 | 0.56264826 |
107 | RPS6KC1 | 0.56264826 |
108 | MATK | 0.55802127 |
109 | MAP3K6 | 0.54878437 |
110 | LCK | 0.54161642 |
111 | CSNK2A1 | 0.53853919 |
112 | IKBKB | 0.52017886 |
113 | ZAK | 0.50900744 |
114 | CSNK2A2 | 0.49641904 |
115 | PLK2 | 0.46380714 |
116 | CDK1 | 0.44317864 |
117 | FGR | 0.42904512 |
118 | CHUK | 0.42885047 |
119 | GRK6 | 0.42605971 |
120 | MAPKAPK2 | 0.42384785 |
121 | CDK6 | 0.42371156 |
122 | MAP2K6 | 0.42075901 |
123 | MAP3K5 | 0.40645270 |
124 | ILK | 0.40644605 |
125 | MELK | 0.37336114 |
126 | PRKCQ | 0.36336384 |
127 | WNK3 | 0.35665558 |
128 | MAP3K4 | 0.35118372 |
129 | ARAF | 0.35029381 |
130 | BCKDK | 0.33991813 |
131 | MARK3 | 0.32657772 |
132 | IKBKE | 0.32524983 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 5.05124594 |
2 | Mismatch repair_Homo sapiens_hsa03430 | 4.18416509 |
3 | Base excision repair_Homo sapiens_hsa03410 | 3.54575284 |
4 | Ribosome_Homo sapiens_hsa03010 | 3.16200568 |
5 | Spliceosome_Homo sapiens_hsa03040 | 3.00763206 |
6 | RNA polymerase_Homo sapiens_hsa03020 | 2.98084946 |
7 | Homologous recombination_Homo sapiens_hsa03440 | 2.96364488 |
8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.93152794 |
9 | Proteasome_Homo sapiens_hsa03050 | 2.90163858 |
10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.64042705 |
11 | Cell cycle_Homo sapiens_hsa04110 | 2.56787877 |
12 | RNA transport_Homo sapiens_hsa03013 | 2.54470168 |
13 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.39090779 |
14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.37476706 |
15 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.18270911 |
16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.12153642 |
17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.01439630 |
18 | Basal transcription factors_Homo sapiens_hsa03022 | 1.88897373 |
19 | RNA degradation_Homo sapiens_hsa03018 | 1.84616152 |
20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.60875876 |
21 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.59668369 |
22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55482312 |
23 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.43710645 |
24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.40778293 |
25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.38749794 |
26 | Parkinsons disease_Homo sapiens_hsa05012 | 1.36740007 |
27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.31559301 |
28 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.29112597 |
29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.29024151 |
30 | Purine metabolism_Homo sapiens_hsa00230 | 1.23440590 |
31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.21643035 |
32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19825460 |
33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.02975071 |
34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98791677 |
35 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.97032896 |
36 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95421105 |
37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94102494 |
38 | Shigellosis_Homo sapiens_hsa05131 | 0.93885202 |
39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92313804 |
40 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.90384157 |
41 | Huntingtons disease_Homo sapiens_hsa05016 | 0.89938828 |
42 | Measles_Homo sapiens_hsa05162 | 0.88487935 |
43 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87665395 |
44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86287364 |
45 | Legionellosis_Homo sapiens_hsa05134 | 0.85783639 |
46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83103223 |
47 | Apoptosis_Homo sapiens_hsa04210 | 0.75642386 |
48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.75188370 |
49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73954895 |
50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73630854 |
51 | Leishmaniasis_Homo sapiens_hsa05140 | 0.71076828 |
52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.70747108 |
53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69469757 |
54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69271129 |
55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68593235 |
56 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.68377199 |
57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67692297 |
58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66462115 |
59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66398801 |
60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62668140 |
61 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.61548237 |
62 | Hepatitis B_Homo sapiens_hsa05161 | 0.61348327 |
63 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.59753706 |
64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59017431 |
65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58704182 |
66 | Influenza A_Homo sapiens_hsa05164 | 0.57191357 |
67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55191772 |
68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54638262 |
69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54582618 |
70 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.54284648 |
71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54251151 |
72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.53581027 |
73 | Protein export_Homo sapiens_hsa03060 | 0.52865402 |
74 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52569325 |
75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52410073 |
76 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52297910 |
77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52201556 |
78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50446322 |
79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50305043 |
80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50156565 |
81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49936990 |
82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48020271 |
83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.47090342 |
84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45373752 |
85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45168332 |
86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44770533 |
87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44616803 |
88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43975250 |
89 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.43831398 |
90 | Lysosome_Homo sapiens_hsa04142 | 0.43042806 |
91 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41461505 |
92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41435543 |
93 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41061030 |
94 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40098789 |
95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39228073 |
96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38860506 |
97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38317994 |
98 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.37864557 |
99 | Phagosome_Homo sapiens_hsa04145 | 0.37637876 |
100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35964867 |
101 | Lysine degradation_Homo sapiens_hsa00310 | 0.35705897 |
102 | Carbon metabolism_Homo sapiens_hsa01200 | 0.34982121 |
103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.34339746 |
104 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34035433 |
105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33888561 |
106 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.32989207 |
107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.32980083 |
108 | Peroxisome_Homo sapiens_hsa04146 | 0.32788047 |
109 | Tuberculosis_Homo sapiens_hsa05152 | 0.32127389 |
110 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.31890275 |
111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.30057172 |
112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29892933 |
113 | Asthma_Homo sapiens_hsa05310 | 0.29298250 |
114 | Platelet activation_Homo sapiens_hsa04611 | 0.29055303 |
115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.28895552 |
116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.28702255 |
117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.27891941 |
118 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.27491349 |
119 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.26513296 |
120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.25995883 |
121 | Pathways in cancer_Homo sapiens_hsa05200 | 0.25927722 |
122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25422837 |
123 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.25328741 |
124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25176845 |
125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.24860183 |
126 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.24128659 |
127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23432038 |
128 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.23363911 |
129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22401846 |
130 | Allograft rejection_Homo sapiens_hsa05330 | 0.21934357 |
131 | Malaria_Homo sapiens_hsa05144 | 0.21645375 |